Rotavirus vaccine effectiveness and impact in Uzbekistan, the first country to introduce in central Asia

• Main Authors: Umid Eraliev (Author), Renat Latipov (Author), Dilorom Tursunova (Author), Annemarie Wasley (Author), Danni Daniels (Author), Umed Ismoilov (Author), Manzura Akramova (Author), Mehri Sultanova (Author), Dilbar Yuldashova (Author), Bahodir Barakaev (Author), Vazira Mutalova (Author), Laziz Tuychiev (Author), Erkin Musabaev (Author), Said Sharapov (Author), Boris Pleshkov (Author), Dovile Videbaek (Author), Shahin Huseynov (Author), Kamola Safaeva (Author), Slavica Mijatovic-Rustempasic (Author), Michael D. Bowen (Author), Umesh D. Parashar (Author), Margaret M. Cortese (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Uzbekistan, the most populous country in central Asia, was the first in the region to introduce rotavirus vaccine into its national immunization program. Rotarix (GlaxoSmithKline Biologicals, RV1) was introduced in June 2014, with doses recommended at age 2 and 3 months. To evaluate vaccine impact,...